Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Small Lymphocytic Lymphoma

Clinical trial condition

Recurrent Small Lymphocytic Lymphoma

Explore clinical trials studying Recurrent Small Lymphocytic Lymphoma. Study availability and eligibility vary by location and protocol.

126 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Small Lymphocytic Lymphoma trial results

Active, Not Recruiting

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

NCT03479268

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
Locations: City of Hope Medical Center Duarte, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

NCT01589302

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT03961672

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Active, Not Recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

NCT02153580

Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

NCT04007029

Conditions: CD19 Positive, CD20 Positive, Chronic Disease, +33 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details